Your Patients Can't Find Avanafil — Here's How to Help

You've prescribed Avanafil (Stendra) because it's the right clinical fit for your patient — maybe they value its rapid 15-minute onset, or they've had fewer side effects compared to other PDE5 inhibitors. But then you hear back: "My pharmacy doesn't carry it."

This is a common scenario in 2026. Avanafil occupies a small but clinically meaningful niche in the ED treatment landscape, and its limited pharmacy shelf presence can frustrate both patients and providers. This guide gives you practical, actionable steps to help your patients successfully fill their Avanafil prescriptions.

Current Availability: What You Need to Know

Avanafil is not in a formal drug shortage. It is manufactured and distributed in both brand (Stendra) and generic formulations. However, practical availability at retail pharmacies is inconsistent due to:

• Low dispensing volume: Avanafil accounts for a small fraction of PDE5 inhibitor prescriptions, so automated pharmacy inventory systems often don't flag it for restocking.
• Generic still maturing: Generic avanafil (Hetero Labs, Camber Pharmaceuticals) launched in mid-to-late 2024. While supply exists in the wholesale channel, not all pharmacies have onboarded it into their regular inventory.
• Insurance non-coverage: Most plans don't cover avanafil, which suppresses prescription volume and further reduces stocking incentives.

For a detailed supply timeline, see our companion briefing: Avanafil Shortage: What Providers and Prescribers Need to Know.

Why Patients Can't Find It

When a patient reports they can't fill their Avanafil prescription, the most common reasons are:

1. Pharmacy doesn't stock it: The most frequent issue. Chain pharmacies especially may not carry avanafil due to low volume.
2. Pharmacy only stocks brand Stendra: Some pharmacies that do carry avanafil only have the expensive brand version, which patients may decline due to cost ($400–$700).
3. Patient doesn't know to ask for generic: Patients may not realize that a less expensive generic (avanafil) is now available and may only ask for "Stendra."
4. Prior authorization delays: For the minority of patients with insurance coverage, PA requirements can add days or weeks to the process.
5. Prescription sent to wrong pharmacy: Patients may have moved, changed pharmacies, or not communicated their preferred location.

What Providers Can Do: 5 Actionable Steps

Step 1: Prescribe Generic Avanafil by Default

Write prescriptions for "avanafil" rather than "Stendra" and allow generic substitution. This gives the pharmacy flexibility to dispense whichever version they can source most quickly. Specify the strength (50 mg, 100 mg, or 200 mg) and quantity clearly.

Step 2: Check Stock Before Sending the Prescription

Use Medfinder for Providers to verify which pharmacies near your patient currently have avanafil in stock. By sending the prescription to a pharmacy that already has it, you eliminate the most common point of failure.

This takes seconds and saves your patient — and your staff — from phone calls, transfers, and repeat visits.

Step 3: Advise Patients to Request a Pharmacy Order

Coach patients with this simple script: "If your pharmacy doesn't have avanafil on the shelf, ask them to order it through their wholesaler. It usually arrives within 1 to 2 business days."

Most pharmacies are willing to place special orders, but patients often don't know to ask. This one piece of anticipatory guidance can resolve the majority of access issues.

Step 4: Consider Independent and Specialty Pharmacies

Independent pharmacies tend to be more accommodating with special orders and may already stock avanafil if they serve a men's health patient population. If your practice has relationships with local independent pharmacies, steer patients there when chains come up empty.

Step 5: Offer Telehealth-Linked Pharmacy Options

For patients comfortable with mail-order, several telehealth platforms dispense avanafil with home delivery. If you're operating in a telehealth practice or hybrid model, this may be the most reliable fulfillment pathway. Share the option proactively rather than waiting for the patient to encounter problems.

Therapeutic Alternatives to Keep in Your Toolkit

When avanafil isn't accessible or the patient is cost-sensitive, these PDE5 inhibitor alternatives are widely available:

• Sildenafil (Viagra): 25–100 mg PRN, onset 30–60 min, duration 4–6 hr. Generic as low as $3–$10/tablet. Most widely stocked.
• Tadalafil (Cialis): 5–20 mg PRN or 2.5–5 mg daily. Onset 30–45 min, duration up to 36 hr. Only PDE5 inhibitor with daily dosing option. Generic $3–$15/tablet.
• Vardenafil (Levitra): 5–20 mg PRN, onset 30–60 min, duration 4–6 hr. ODT (Staxyn) formulation available. Generic $10–$30/tablet.

All share the same absolute contraindication with nitrates and caution with alpha-blockers. For a patient-facing comparison: Alternatives to Avanafil.

Workflow Tips for Your Practice

Consider building these practices into your prescribing workflow for avanafil and other less common medications:

• Pre-check availability: Make Medfinder stock checks part of your e-prescribing workflow for non-formulary or niche drugs.
• Set expectations at the visit: Tell patients upfront that avanafil may not be on every pharmacy shelf and give them the "ask to order" guidance before they leave.
• Document preferred pharmacy: Confirm the patient's preferred pharmacy at each visit, especially if they've had fill issues previously.
• Have a backup plan ready: When prescribing avanafil, discuss an alternative PDE5 inhibitor at the same visit so the patient knows what to do if they can't fill the primary prescription.
• Share savings resources: Point cost-conscious patients to discount card programs (GoodRx, SingleCare) and our savings guide: How to Save Money on Avanafil.

Provider-Specific Resources

• Medfinder for Providers — Real-time pharmacy stock checking
• Avanafil Drug Interactions — Clinical interaction reference
• Avanafil Mechanism of Action — Pharmacology overview
• How to Help Patients Save Money on Avanafil — Provider-focused cost reduction strategies

Final Thoughts

Avanafil is a clinically valuable medication that deserves a place in the ED treatment toolkit. Its limited pharmacy availability is a logistics challenge, not a reflection of its efficacy or safety. By taking a few proactive steps — prescribing generics, checking stock before sending prescriptions, and equipping patients with the right information — you can significantly improve your patients' chances of getting the medication you prescribed.

The tools exist. Medfinder for Providers puts real-time stock data at your fingertips. The rest is about building awareness into your workflow and empowering your patients to advocate for their own access.